🇮🇪Ireland
16°C Partly Cloudy · Dublin
Live Updates
--:--:-- IST
Contributor sign in
Latest
Clinical Trials in Germany / NCT05989685
Recruiting Observational

Psychometric Validation of the Camouflaging Autistic Traits Questionnaire

NCT05989685 · tracked via the Priya Life Science Germany tracker
Phase
Observational
Started
2023-02-20
Last updated
2025-03-12

Condition(s) studied

Autism Spectrum Disorder

Study summary

For many affected individuals, despite impairment and distress, autism spectrum disorder (ASD) is recognized and diagnosed late, in school age, adolescence, or even in adulthood, which could be due, among other things, to the use of compensatory strategies such as so-called "camouflaging" by the respective individual. In order to better investigate and quantify these adaptive and compensatory strategies of individuals with autism, the Camouflaging Autistic Traits Questionnaire (CAT-Q) has recently been developed and validated in the English-speaking world. The CAT-Q is designed to assess the extent of camouflaging behavior, in which autistic individuals consciously or unconsciously attempt to conceal or attenuate their autistic traits in order to better adapt to social situations. So far, however, there is no German-language questionnaire that can be used to validly assess camouflaging. The aim of the planned research project is to psychometrically validate the CAT-Q in German-speaking adolescents aged 13-21 years. The validation of the CAT-Q represents an important basis for further research on the construct camouflaging and can subsequently contribute to an improvement of diagnostics as well as support the development of individual treatment approaches.

Eligibility

Sex
ALL
Min age
13 Years
Max age
21 Years
Healthy volunteers
No
Inclusion Criteria study group: \- patients who meet the principal diagnosis of ASD, which includes atypical autism (ICD-10: F84.1) and Asperger syndrome (ICD-10: F84.5), and are between the ages of 13 and 21 years old. Exclusion Criteria study group: * Dementia / below average cognitive abilities (IQ \< 85) * lack of German language skills * severe visual or hearing impairment (uncorrected) Inclusion Criteria control group: \- Adolescents who do not have a lifetime principal diagnosis of a psychiatric disorder (ICD-10-GM-2016: F10 - F69) and are between 13 and 21 years old. Exclusion Criteria Control Group: * dementia / below average general cognitive ability (IQ \< 85) * lack of German language skills * severe impairment of vision or hearing (not corrected).

Primary outcome measure(s)

Trial sites (1)

FacilityCityRegionStatus
University Medical Center Hamburg-Eppendorf Hamburg Germany Recruiting

More Universitätsklinikum Hamburg-Eppendorf trials in Germany

Other trials for the same condition

Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT05989685 on ClinicalTrials.gov ↗ ← All trials in Germany